Jack Meehan
Stock Analyst at Barclays
(3.06)
# 1,198
Out of 5,163 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $263.80 | +9.93% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $111.51 | +12.10% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $286.57 | +0.50% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $7.93 | +316.14% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $118.94 | +173.25% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $13.54 | +40.32% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $199.70 | -50.43% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $98.33 | +83.06% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $4.66 | +114.59% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $164.72 | +0.78% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $75.12 | -42.76% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $155.46 | -0.94% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $262.80 | +63.62% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $264.40 | +62.63% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $17.10 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $33.75 | +42.22% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,173.74 | -42.07% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $68.26 | -56.05% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $464.37 | -35.40% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $0.79 | +4,963.29% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $263.80
Upside: +9.93%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $111.51
Upside: +12.10%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $286.57
Upside: +0.50%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $7.93
Upside: +316.14%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $118.94
Upside: +173.25%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $13.54
Upside: +40.32%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $199.70
Upside: -50.43%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $98.33
Upside: +83.06%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $4.66
Upside: +114.59%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $164.72
Upside: +0.78%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $75.12
Upside: -42.76%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $155.46
Upside: -0.94%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $262.80
Upside: +63.62%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $264.40
Upside: +62.63%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $17.10
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $33.75
Upside: +42.22%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,173.74
Upside: -42.07%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $68.26
Upside: -56.05%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $464.37
Upside: -35.40%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $0.79
Upside: +4,963.29%